详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Zhang Shirong[1] ; Wang Wenxian[2] ; Xu Chunwei[3,4] ; Zhang Yongchang[5] ; Cai Xiuyu[6] ; Wang Qian[7] ; Song Zhengbo[2] ; Li Ziming[8] ; Yu Jinpu[9] ; Zhong Wenzhao[10] ; Wang Zhijie[11] ; Liu Jingjing[12] ; Liu Anwen[13] ; Li Wen[14] ; Zhan Ping[4] ; Liu Hongbing[4] ; Lv Tangfeng[4] ; Miao Liyun[15] ; Min Lingfeng[16] ; Lin Gen[17] ; Huang Long[13] ; Yuan Jingping[18] ; Jiang Zhansheng[19] ; Pu Xingxiang[20] ; Rao Chuangzhou[21] ; Lv Dongqing[22] ; Yu Zongyang[23] ; Li Xiaoyan[24] ; Tang Chuanhao[25] ; Zhou Chengzhi[26] ; Zhang Junping[27] ; Guo Hui[28] ; Chu Qian[29] ; Meng Rui[30] ; Liu Xuewen[31] ; Wu Jingxun[32] ; Zhou Jin[33]

; Zhu Zhengfei[34] ; Pan Weiwei[35] ; Dong Xiaowei[36] ; Pang Fei[36] ; Wang Kai[36] ; Yao Chao[36] ; Lin Guomin[36] ; Li Site[37] ; Yang Zhi[37] ; Luo Jiancheng[38] ; Jia Hongtao[38] ; Nie Xiuqing[39] ; Wang Liping[40] ; Zhu Youcai[41] ; Hu Xiao[42] ; Xie Yanru[43] ; Lin Xinqing[26] ; Cai Jing[13] ; Xia Yang[14] ; Feng Huijing[27] ; Wang Lin[44] ; Du Yingying[45] ; Yao Wang[46] ; Shi Xuefei[47] ; Niu Xiaomin[8] ; Yuan Dongmei[4] ; Yao Yanwen[4] ; Kang Jing[10] ; Zhang Jiatao[10] ; Zhang Chao[10] ; Gao Wenbin[48] ; Huang Jianhui[43] ; Zhang Yinbin[49] ; Sun Pingli[50] ; Wang Hong[51] ; Ye Mingxiang[4] ; Wang Dong[4] ; Wang Zhaofeng[4] ; Wan Bing[52] ; Lv Donglai[53] ; Yu Genhua[54] ; Shi Lin[55] ; Xia Yuanli[41] ; Gao Feng[56] ; Zhang Xiaochen[57] ; Xu Tao[58] ; Zhou Wei[3] ; Wang Haixia[3] ; Liu Zhefeng[51] ; Yang Nong[5] ; Wu Lin[20] ; Wang Qiming[59] ; Wang Guansong[60] ; Hong Zhuan[61] ; Wang Jiandong[62] ; Fang Meiyu[2] ; Fang Yong[63] ; Zhang Yiping[2] ; Song Yong[4] ; Ma Shenglin[64,*1] ; Fang Wenfeng[65,*2] ; Lu Yuanzhi[66,*3] ;

机构： [1]Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China. [2]Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China. [3]Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China. [4]Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China. [5]Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. [6]Department of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. [7]Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. [8]Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. [9]Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. [10]Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China. [11]State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [12]Department of Thoracic Cancer, Jilin Cancer Hospital, Changchun, China. [13]Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China. [14]Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China. [15]Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China. [16]Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, China. [17]Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, China. [18]Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China. [19]Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. [20]Department of Medical Oncology, Lung Cancer and Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. [21]Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China. [22]Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, China. [23]Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, China. [24]Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [25]Department of Medical Oncology, Peking University International Hospital, Beijing, China. [26]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease [27]Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China. [27]Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China. [28]Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. [29]Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [30]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [31]Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, China. [32]Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, China. [33]Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, China. [34]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. [35]Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, China. [36]Department of Medical, Shanghai OrigiMed Co., Ltd, Shanghai, China. [37]Department of IVD Medical Marketing, 3D Medicines, Shanghai, China. [38]Department of Medical, Aiyi Technology, Beijing, China. [39]Department of Clinical Trial, Novocodex Biopharmaceutic, Shaoxing, China. [40]Department of Oncology, Baotou Cancer Hospital, Baotou, China. [41]Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China. [42]Zhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China. [43]Department of Oncology, Lishui Municipal Central Hospital, Lishui, China. [44]Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China. [45]Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. [46]Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. [47]Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, China. [48]Department of Oncology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China. [49]Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China. [50]Department of Pathology, The Second Hospital of Jilin University, Changchun, China. [51]Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, China. [52]Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. [53]Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, China. [54]Department of Radiation Oncology, Zhebei Mingzhou Hospital, Huzhou, China. [55]Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. [56]Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. [57]Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. [58]Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. [59]Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China. [60]Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, China. [61]Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. [62]Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China. [63]Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China. [64]Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China. [65]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. [66]Department of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 3 区医学

小类 | 4 区肿瘤学 4 区呼吸系统

最新[2023]版：

大类 | 3 区医学

小类 | 4 区肿瘤学 4 区呼吸系统

JCR分区：

出版当年[2023]版：

Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY

最新[2023]版：

Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY

第一作者：

第一作者机构： [1]Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.

共同第一作者：

通讯作者：

通讯机构： [64]Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China. [65]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. [66]Department of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, China. [*1]Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine,Hangzho Zhejiang 310 006, China. [*2]Department of Medical Oncology,Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China,Collaborative Innovation Center for CancerMedicine, Guangzhou, Guangdong 510 060,China. [*3]Department of Clinical Pathology,The First Affiliated Hospital Of Jinan University,Guangzhou Guangdong 510 630, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer

文献详情